Generation of endogenous tumour necrosis factor-α in MOLT-4 cells during the acute replication phase of human immunodeficiency virus type 1 determines the subsequent latent infection

Journal of General Virology

Volumn 79, Issue 2, 1998, Pages 221-229

  Fujinaga, Koh ^a   Nakaya, Takaaki ^a   Ikuta, Kazuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL CLONE; CELL DESTRUCTION; CELL TYPE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS GENE; VIRUS REPLICATION;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031984964     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-2-221     Document Type: Article

References (33)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Robson, A. & Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Journal of Virology 59, 284-291.
2. Cao, Y., Ho, D. D., Todd, J., Kokka, R., Urdea, M., Lifson, J. D., Piatak, M., Jr, Chen, S., Hahn, B. H., Saag, M. S. & Shaw, G. M. (1995). Clinical evaluation of branched DNA signal amplification for quantifying HIV type I in human plasma. AIDS Research and Human Retroviruses 11, 353-361.
3. Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S. & Rabson, A. B. (1989). Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proceedings of the National Academy of Sciences, USA 86, 5974-5978.
4. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K. & Haase, A. T. (1993a). Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362.
5. Embretson, J., Zupancic, M., Beneke, J., Till, M., Wolinsky, S., Ribas, J. L., Burke, A. & Haase, A. T. (1993b). Analysis of human immunodeficiency virus-infected tissues by amplification of in situ hybridization reveals latent and permissive infections at single-cell resolution. Proceedings of the National Academy of Sciences, USA 90, 357-361.
6. Fujinaga, K., Zhong, Q., Nakaya, T., Kameoka, M., Meguro, T., Yamada, K. & Ikuta, K. (1995). Extracellular Nef protein regulates productive HIV-1 infection from latency. Journal of Immunology 155, 5289-5298.
7. Fujinaga, K., Nakamura, Y., Zhong, Q., Nakaya, T. & Ikuta, K. (1996). Growth dominance of a revertant virus generated during in vitro serial passage of nef frameshift mutant of HIV-1. Biochemical and Biophysical. Research Communications 229, 96-101.
8. Herbein, G., Montaner, L. J. & Gordon, S. (1996). Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. Journal of Virology 70, 7388-7397.
9. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
10. Kikukawa, R., Koyanagi, Y., Harada, S., Kobayashi, N., Hatanaka, M. & Yamamoto, N. (1986). Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemia T-cell line Molt-4. Journal of Virology 57, 1159-1162.
11. Kishi, M., Nishino, Y., Sumiya, M., Ohki, K., Kimura, T., Goto, T., Nakai, M., Kakinuma, M. & Ikuta, K. (1992). Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. Journal of General Virology 73, 77-87.
12. Kishi, M., Zheng, Y.-H., Bahmani, M. K., Tokunaga, K., Takahashi, H., Kakinuma, M., Lai, P. K., Nonoyama, M., Luftig, R. B. & Ikuta, K. (1995). Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive Tcells. Journal of Virology 69, 7507-7518.
13. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. & Ho, D. D. (1994). Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68, 4650-4655.
14. Levy, J. A. (1993). Pathogenesis of human immunodeficiency virus infection. Microbiology Reviews 57, 183-289.
15. Levy, D. N., Refaeli, Y., MacGregor, R. R. & Weiner, D. B. (1994). Serum Vpr regulates productive infection and latency ol human immunodeficiency virus type I. Proceedings of the National Academy of Sciences, USA 91, 10873-10877.
16. Levy, D. N., Refaeli, Y. & Weiner, D. B. (1995). Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. Journal of Virology 69, 1243-1252.
17. Matsuyama, T., Hamamoto, Y., Soma, G., Mizuno, D., Yamamoto, N. & Kobayashi, N. (1989). Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication. Journal of Virology 63, 2504-2509.
18. Michael, N. L., Mo, T., Merzouki, A., O'Shaughnessy, M., Oster, C., Burke, D. S., Redfield, R. R., Birx, D. L. & Cassol, S. A. (1995). Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. Journal of Virology 69, 1868-1877.
19. Minowada, J., Ohnuma, T. & Moore, D. E. (1972). Rosette forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. Journal of the National Cancer Institute 49, 891-895.
20. Miyoshi, I., Taguchi, H., Kubonishi, I., Yoshimoto, S., Ohtsuki, Y., Shiraishi, Y. & Akagi, T. (1982). Type C virus producing cell lines derived from adult T cell leukemia. In Adult T Cell Leukemia and Related Diseases, GANN Monograph on Cancer Research, no. 28, pp. 219-228. Edited by M. Hanaoka, K. Takatsuki & M. Shimoyama. Tokyo: Japan Scientific Societies Press.
21. Nakaya, T., Fujinaga, K., Kishi, M., Oka, S., Kurata, T., Jones, I. M. & Ikuta, K. (1994). Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells. FEBS Letters 354, 17-22.
22. Nakaya, T., Fujinaga, K., Doi, H., Suzuki, S., Takahashi, H., Nishino, Y., Kishi, M., Azuma, I., Luftig, R. B. & Ikuta, K. (1996). Serial passage of human immunodeficiency virus type 1, generates misalignment deletions in non-essential accessory genes. Virus Research 46, 139-147.
23. Nishino, Y., Kishi, M., Sumiya, M., Ogawa, K., Adachi, A., Maotani-Imai, K, Kato, S., Hirai, K. & Ikuta, K. (1991 ). Human immunodeficiency virus type 1 vif, vpr, and vpu mutations can produce persistently infected cells. Archives of Virology 120, 181-192.
24. Nishino, Y., Nakaya, T., Fujinaga, K., Kishi, M., Azuma, I. & Ikuta, K. (1994). Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild type but not nef mutant virus. Journal of General Virology 75, 2241-2251.
25. Osborn, L., Kunkel, S. & Nabel, G. J. (1989). Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proceedings of the National Academy of Sciences, USA 86, 2336-2340.
26. Panteleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C., Orenstein, J. M., Kotler, D. P. & Fauci, A. S. (1993). HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-358.
27. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370, 463-467.
28. Patterson, B. K., Till, M., Otto, P., Goolsby, C., Furtado, M. R., McBride, L. J. & Wolinsky, S. M. (1993). Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260, 976-979.
29. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586.
30. Poli, G. & Fauci, A. S. (1992). The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Research and Human Retroviruses 8, 191-197.
31. Rosenberg, Z. F. & Fauci, A. S. (1990). Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunology Today 11, 176-180.
32. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Saag, M. S. & Shaw, G. M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
33. Yunoki, M., Maotani-Imai, K., Kusuda, H., Motoyama, M., Miyake, S., Imai, H., Shin, Y. S., Kato, S., Sano, K., Morita, C., Nakai, M., Hirai, K. & Ikuta, K. (1991). Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1. Archives of Virology 116, 143-158.